Aikawa H, Maeda H, Nakashima A, Ashizawa A, Mori H, Azimu A, Hirao K, Isomoto I, Matuoka Y, Monzen Y
Dept. of Radiology, Medical College of Oita.
Gan No Rinsho. 1989 Apr;35(5):620-4.
Reported is a case that was treated successfully with a percutaneous intratumoral injection of a CDDP-PC-Lipiodol Suspension (CPLS) of the viable tumor cells of a hepatoma after arterial injection therapy. Although the size of the viable tumor cells remained almost unchanged, a marked reduction in the level of the plasma AFP (484 ng/ml-35 ng/ml) was obtained after the percutaneous injection. No major complication was encountered except for minimal vomiting and mild transient abnormalities of the liver functions.
报告了一例在动脉注射治疗后经皮向肝癌存活肿瘤细胞内注射顺铂-聚氰基丙烯酸正丁酯-碘油混悬液（CPLS）成功治疗的病例。尽管存活肿瘤细胞大小几乎未变，但经皮注射后血浆甲胎蛋白水平显著降低（从484 ng/ml降至35 ng/ml）。除轻微呕吐和肝功能轻度短暂异常外，未出现重大并发症。
